Chinese Medical Journal (Jan 2022)
CD19-targeted chimeric antigen receptor-modified T cells induce remission in patients with relapsed acute B lymphoblastic leukemia after umbilical cord blood transplantation
Abstract
No abstracts available.
Chinese Medical Journal (Jan 2022)